Hyperpolarized 3he ventilation defects used to predict pulmonary exacerbations in mild to moderate chronic obstructive pulmonary disease

Radiology

Volumn 273, Issue 3, 2014, Pages 887-896

  Kirby, Miranda ^a,b   Pike, Damien ^a,b   Coxson, Harvey O ^c   McCormack, David G ^b   Parraga, Grace ^a,b  

^a ROBARTS RESEARCH INSTITUTE   (Canada)

^b UNIVERSITY OF WESTERN ONTARIO   (Canada)

^c VANCOUVER GENERAL HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; APPARENT DIFFUSION COEFFICIENT; ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; COMPUTED TOMOGRAPHY SCANNER; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE EXACERBATION; DISEASE SEVERITY; EXPERIMENTAL LOCOMOTOR ACTIVITY TEST; FEMALE; FOLLOW UP; FORCED EXPIRATORY VOLUME; FORCED VITAL CAPACITY; HELIUM 3 MAGNETIC RESONANCE IMAGING; HIGH RISK POPULATION; HOSPITALIZATION; HUMAN; IMAGE ANALYSIS; LUNG EMPHYSEMA; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SCANNER; PATIENT IDENTIFICATION; PATIENT MONITORING; PHENOTYPE; PLETHYSMOGRAPHY; PREDICTIVE VALUE; QUANTITATIVE ANALYSIS; RADIOLOGICAL PARAMETERS; RESPIRATORY TRACT PARAMETERS; SIX MINUTE WALK TEST; SPIROMETRY; ST. GEORGE RESPIRATORY QUESTIONNAIRE; VENTILATION DEFECT PERCENTAGE; DIFFUSION WEIGHTED IMAGING; LUNG FUNCTION TEST; PATHOPHYSIOLOGY; PROCEDURES; VERY ELDERLY;

BRONCHODILATING AGENT; HELIUM; ISOTOPE; SALBUTAMOL;

AGED; AGED, 80 AND OVER; ALBUTEROL; BRONCHODILATOR AGENTS; DIFFUSION MAGNETIC RESONANCE IMAGING; FEMALE; HELIUM; HUMANS; ISOTOPES; MALE; MIDDLE AGED; PLETHYSMOGRAPHY; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RESPIRATORY FUNCTION TESTS; SPIROMETRY; TOMOGRAPHY, X-RAY COMPUTED;

EID: 84916629436     PISSN: 00338419     EISSN: 15271315     Source Type: Journal    
DOI: 10.1148/radiol.14140161     Document Type: Article

References (54)

1. Dalal AA, Shah M, D'Souza AO, Rane P. Costs of COPD exacerbations in the emergency department and inpatient setting. Respir Med 2011;105(3):454-460
2. Donaldson GC, Seemungal TA, Bhowmik A, Wedzicha JA. Relationship between exacerbation frequency and lung function decline in chronic obstructive pulmonary disease. Thorax 2002;57(10):847-852
3. Seemungal TA, Donaldson GC, Paul EA, Bestall JC, Jeffries DJ, Wedzicha JA. Effect of exacerbation on quality of life in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1998;157(5 Pt 1):1418-1422
4. Soler-Cataluña JJ, Martínez-García MA, Román Sánchez P, Salcedo E, Navarro M, Ochando R. Severe acute exacerbations and mortality in patients with chronic obstructive pulmonary disease. Thorax 2005; 60(11):925-931
5. Gudmundsson G, Ulrik CS, Gislason T, et al. Long-term survival in patients hospitalized for chronic obstructive pulmonary disease: A prospective observational study in the Nordic countries. Int J Chron Obstruct Pulmon Dis 2012;7:571-576
6. Hurst JR, Vestbo J, Anzueto A, et al. Susceptibility to exacerbation in chronic obstructive pulmonary disease. N Engl J Med 2010;363(12):1128-1138
7. Donaldson GC, Wedzicha JA. COPD exacerbations. 1: Epidemiology. Thorax 2006;61(2):164-168
8. Wilkinson T, Wedzicha JA. Strategies for improving outcomes of COPD exacerbations. Int J Chron Obstruct Pulmon Dis 2006;1(3):335-342
9. Burgel PR, Nesme-Meyer P, Chanez P, et al. Cough and sputum production are associated with frequent exacerbations and hospitalizations in COPD subjects. Chest 2009;135(4):975-982
10. Tulek B, Kivrak AS, Ozbek S, Kanat F, Suerdem M. Phenotyping of chronic obstructive pulmonary disease using the modified Bhalla scoring system for high-resolution computed tomography. Can Respir J 2013;20(2):91-96
11. Han MK, Kazerooni EA, Lynch DA, et al. Chronic obstructive pulmonary disease exacerbations in the COPDGene study: Associated radiologic phenotypes. Radiology 2011;261(1):274-282
12. Kirby M, Owrangi A, Svenningsen S, et al. On the role of abnormal DL(CO) in exsmokers without airflow limitation: symptoms, exercise capacity and hyperpolarised helium-3 MRI. Thorax 2013;68(8):752-759
13. 3He MR imaging. Radiology 2006;239(3):875-883
14. 3He MRI. Eur J Radiol 2005;54(3):352-358
15. 3He MRI. Acad Radiol 2005;12(11):1385-1393
16. Fain SB, Gonzalez-Fernandez G, Peterson ET, et al. Evaluation of structure-function relationships in asthma using multidetector CT and hyperpolarized He-3 MRI. Acad Radiol 2008;15(6):753-762
17. 3He-MRI using MSCT and pulmonary function tests as references. Eur J Radiol 2009;71(2):257-263
18. 129Xe MR imaging in healthy volunteers and patients with chronic obstructive pulmonary disease. Radiology 2012;265(2):600-610
19. 3He diffusion MRI and histology in pulmonary emphysema. Magn Reson Med 2006;56(6):1293-1300
20. 3He gas. Radiology 1999;210(3):851-857
21. Altes TA, Rehm PK, Harrell F, Salerno M, Daniel TM, De Lange EE. Ventilation imaging of the lung: comparison of hyperpolarized helium-3 MR imaging with Xe-133 scintigraphy. Acad Radiol 2004;11(7):729-734
22. 3He ventilation defects and apparent diffusion coefficients in chronic obstructive pulmonary disease: preliminary results at 3.0 Tesla. Invest Radiol 2007;42(6):384-391
23. 3He MR imaging. Radiology 2011;261(1):283-292
24. 3He functional magnetic resonance imaging of bronchoscopic airway bypass in chronic obstructive pulmonary disease. Can Respir J 2012;19(1):41-43
25. Kirby M, Mathew L, Wheatley A, Santyr GE, McCormack DG, Parraga G. Chronic obstructive pulmonary disease: longitudinal hyperpolarized (3)He MR imaging. Radiology 2010;256(1):280-289
26. Svenningsen S, Kirby M, Starr D, et al. What are ventilation defects in asthma? Thorax 2014;69(1):63-71
27. Kirby M, Kanhere N, Etemad-Rezai R, Mc- Cormack DG, Parraga G. Hyperpolarized helium-3 magnetic resonance imaging of chronic obstructive pulmonary disease exacerbation. J Magn Reson Imaging 2013;37(5): 1223-1227
28. Global Initiative for Chronic Lung Disease. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. Updated 2013. 2013
29. Miller MR, Hankinson J, Brusasco V, et al. Standardisation of spirometry. Eur Respir J 2005;26(2):319-338
30. Macintyre N, Crapo RO, Viegi G, et al. Standardisation of the single-breath determination of carbon monoxide uptake in the lung. Eur Respir J 2005;26(4):720-735
31. Wanger J, Clausen JL, Coates A, et al. Standardisation of the measurement of lung volumes. Eur Respir J 2005;26(3):511-522
32. Jones PW, Quirk FH, Baveystock CM. The St George's Respiratory Questionnaire. Respir Med 1991;85(Suppl B):25-31; discussion 33-37
33. Enright PL. The six-minute walk test. Respir Care 2003;48(8):783-785
34. Vestbo J, Anderson W, Coxson HO, et al. Evaluation of COPD Longitudinally to Identify Predictive Surrogate End-points (ECLIPSE). Eur Respir J 2008;31(4):869-873
35. 3He magnetic resonance functional imaging semiautomated segmentation. Acad Radiol 2012;19(2):141-152
36. Woodhouse N, Wild JM, Paley MN, et al. Combined helium-3/proton magnetic resonance imaging measurement of ventilated lung volumes in smokers compared to never-smokers. J Magn Reson Imaging 2005;21(4):365-369
37. Kirby M, Heydarian M, Wheatley A, Mc- Cormack DG, Parraga G. Evaluating bronchodilator effects in chronic obstructive pulmonary disease using diffusion-weighted hyperpolarized helium-3 magnetic resonance imaging. J Appl Physiol (1985) 2012;112(4):651-657
38. Nakano Y, Muro S, Sakai H, et al. Computed tomographic measurements of airway dimensions and emphysema in smokers. Correlation with lung function. Am J Respir Crit Care Med 2000;162(3 Pt 1):1102-1108
39. Gevenois PA, de Maertelaer V, De Vuyst P, Zanen J, Yernault JC. Comparison of computed density and macroscopic morphometry in pulmonary emphysema. Am J Respir Crit Care Med 1995;152(2):653-657
40. Mishima M, Hirai T, Itoh H, et al. Complexity of terminal airspace geometry assessed by lung computed tomography in normal subjects and patients with chronic obstructive pulmonary disease. Proc Natl Acad Sci U S A 1999;96(16):8829-8834
41. Lambert D. Zero-inflated Poisson regression, with an application to defects in manufacturing. Technometrics 1992;34(1):1-14
42. Gershon AS, Guan J, Victor JC, Goldstein R, To T. Quantifying health services use for chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2013;187(6):596-601
43. Mittmann N, Kuramoto L, Seung SJ, Haddon JM, Bradley-Kennedy C, Fitzgerald JM. The cost of moderate and severe COPD exacerbations to the Canadian healthcare system. Respir Med 2008;102(3): 413-421
44. Dalal AA, Christensen L, Liu F, Riedel AA. Direct costs of chronic obstructive pulmonary disease among managed care patients. Int J Chron Obstruct Pulmon Dis 2010;5:341-349
45. Greenberg SB, Allen M, Wilson J, Atmar RL. Respiratory viral infections in adults with and without chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2000;162(1):167-173
46. Galbán CJ, Han MK, Boes JL, et al. Computed tomography-based biomarker provides unique signature for diagnosis of COPD phenotypes and disease progression. Nat Med 2012;18(11):1711-1715
47. Hogg JC, Macklem PT, Thurlbeck WM. Site and nature of airway obstruction in chronic obstructive lung disease. N Engl J Med 1968;278(25):1355-1360
48. Marshall H, Deppe MH, Parra-Robles J, et al. Direct visualisation of collateral ventilation in COPD with hyperpolarised gas MRI. Thorax 2012;67(7):613-617
49. Martínez-García MA, Soler-Cataluña JJ, Donat Sanz Y, et al. Factors associated with bronchiectasis in patients with COPD. Chest 2011;140(5):1130-1137
50. Martínez-García MA, de la Rosa Carrillo D, Soler-Cataluña JJ, et al. Prognostic value of bronchiectasis in patients with moderate- to-severe chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2013;187(8):823-831
51. Lutterbey G, Gieseke J, von Falkenhausen M, Morakkabati N, Schild H. Lung MRI at 3.0 T: A comparison of helical CT and highfield MRI in the detection of diffuse lung disease. Eur Radiol 2005;15(2):324-328
52. Deimling M, Jellus V, Geiger B, Chefd'hotel C. Time resolved lung ventilation imaging by Fourier decomposition [abstr]. In: Proceedings of the Sixteenth Meeting of the International Society for Magnetic Resonance in Medicine. Berkeley, Calif: International Society for Magnetic Resonance in Medicine, 2008; 2639
53. Bauman G, Puderbach M, Deimling M, et al. Non-contrast-enhanced perfusion and ventilation assessment of the human lung by means of Fourier decomposition in proton MRI. Magn Reson Med 2009;62(3):656-664
54. Ohno Y, Hatabu H, Takenaka D, Van Cauteren M, Fujii M, Sugimura K. Dynamic oxygen- enhanced MRI reflects diffusing capacity of the lung. Magn Reson Med 2002;47(6): 1139-1144